While glycoprotein (GP) IIb/IIIa inhibitors have been widely studied in ischemic stroke, cangrelor remains less explored. Objective To evaluate the safety and efficacy of cangrelor compared with GPIIb ...

Platelets in Cardiovascular Disease provides an in-depth and current coverage of relevant platelet biology and antiplatelet therapy that is in clinical use today and potentially for the future. The ...

To overcome this limitation, we hypothesized that platelet glycoprotein IIb/IIIa–targeted microbubbles (platelet-targeted microbubbles) could be used to increase the avidity of microbubbles to ...

The antithrombotic efficacy of the monoclonal antibodies 6B4-Fab and MA-16N7C2 against platelet glycoprotein (GP) Ib and GP IIb/IIIa, respectively, on acute platelet-mediated thrombosis was evaluated ...